Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 12.98M P/E - EPS this Y 20.60% Ern Qtrly Grth -
Income -38.37M Forward P/E -0.19 EPS next Y 56.20% 50D Avg Chg -10.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -16.00%
Dividend N/A Price/Book 0.68 EPS next 5Y - 52W High Chg -77.00%
Recommedations 2.00 Quick Ratio 1.79 Shares Outstanding 16.43M 52W Low Chg 66.00%
Insider Own 1.52% ROA -63.74% Shares Float 15.34M Beta 2.36
Inst Own 7.57% ROE -355.35% Shares Shorted/Prior 1.23M/0.98M Price 1.00
Gross Margin - Profit Margin - Avg. Volume 51,474 Target Price 6.50
Oper. Margin - Earnings Date May 10 Volume 121,900 Change -2.91%
About Iterum Therapeutics plc

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Iterum Therapeutics plc News
04/02/24 Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
03/28/24 Q4 2023 Iterum Therapeutics PLC Earnings Call
03/28/24 Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
03/21/24 Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
03/15/24 Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
03/07/24 Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
03/06/24 Iterum Therapeutics Provides Business Update
02/01/24 Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC
01/30/24 Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
12/04/23 Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
11/15/23 Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript
11/15/23 Q3 2023 Iterum Therapeutics PLC Earnings Call
11/14/23 Iterum Therapeutics Reports Third Quarter 2023 Financial Results
11/07/23 Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023
07:00 AM Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
10/12/23 Iterum Therapeutics to Present Data at IDWeek 2023
08/11/23 Q2 2023 Iterum Therapeutics PLC Earnings Call
08/11/23 Iterum Therapeutics Reports Second Quarter 2023 Financial Results
08/04/23 Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023
06/27/23 Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
ITRM Chatroom

User Image haily_haily Posted - 7 hours ago

$ITRM what’s happening in this beeswax

User Image Adamantia Posted - 10 hours ago

$ITRM

User Image Mascotman Posted - 15 hours ago

$ITRM volume of 23.5k. I think that’s the lowest ITRM I have seen to date.

User Image Baruke Posted - 19 hours ago

$ITRM no volume to speak of. Guess this isn't ramp up week

User Image Baruke Posted - 22 hours ago

$ITRM let's get to the 1.65-1.70 range today, shall we?

User Image chinascamstockrock Posted - 1 day ago

$ITRM years of nothing

User Image Adamantia Posted - 1 day ago

$ITRM best plays are ITRM And AMC$

User Image chinascamstockrock Posted - 1 day ago

$ITRM what a pos

User Image LibsRot Posted - 1 day ago

$ITRM Wouldn’t be surprised if the crooked hedge fund losers hold the price back even after NDA submission, working to weed out retail investors before acquisition and/or FDA approval end of year.

User Image Baruke Posted - 1 day ago

$ITRM looking good for day 1 of (hopefully) 5. Maybe it'll manage to get to 2 before the NDA.

User Image Michelleinvestor Posted - 1 day ago

$ITRM got back in today. Seems like the longest to wait would be May 15 because the press release said first half of the second quarter.

User Image Moamen22 Posted - 1 day ago

$ITRM the approval is around the corner. Last chance 😎

User Image Rroper Posted - 1 day ago

$ITRM Still in the loading zone. Get em while you can.

User Image Adamantia Posted - 1 day ago

$ITRM

User Image Baruke Posted - 1 day ago

$ITRM fingers crossed to start seeing that creep up today. If we see consistent 3-5% days all week, NDA will likely be next week.

User Image vic1torious Posted - 4 days ago

$ITRM I really think Fishman will drag his feet all the way to June to submit the NDA gives me an opportunity to bring my average down

User Image Rroper Posted - 4 days ago

$ITRM Hope everyone is loading in this zone. Getting close to blast off. You wont be able to catch it.

User Image Baruke Posted - 5 days ago

$ITRM since the ramp up hasn't started yet, my April 22 guesstimate was most apparently wrong. Maybe we'll start seeing some NDA buildup next week?

User Image smokinMcds Posted - 5 days ago

$ITRM why so stale? Figure we see either up or down, something seems fishy with new on horizon.

User Image TROYTIPTON Posted - 6 days ago

$ITRM You can't beat ITRM if you are looking for near-daily opportunities to average DOWN...they have provided a solid downward trajectory to investors since 2018...over -99% DOWN already....load the boats!!!! What a gem!!!

User Image vic1torious Posted - 6 days ago

$ITRM shorts are definitely adding.

User Image Baruke Posted - 6 days ago

$ITRM if the gaps in the books are any indication, all it will take is for VMA5 to hit and sustain around 50k for about 10 minutes to tickle 2

User Image Baruke Posted - 1 week ago

$ITRM bought 7k. 10k total now. Let's get that beautiful NDA Monday.

User Image Bobcar888 Posted - 1 week ago

$ITRM 1.45? You got my attention --

User Image vic1torious Posted - 1 week ago

$ITRM I’m gonna keep adding till they drop the hammer on these shorts.

User Image Michelleinvestor Posted - 1 week ago

$ITRM I sold a bunch today and put it in sls. I like this one but I am still a little bitter about the debacle a few years ago so I suddenly got cold feet. I might be back since I am fickle. New UTI treatments are needed, so I like the product but I am just sick of waiting on it.

User Image Rroper Posted - 1 week ago

$ITRM Loaded a few more. Its in the zone. Any cheaper is a gift.

User Image Baruke Posted - 1 week ago

$ITRM come on and make my email ding. I wanna load up on my primary while it's being supressed.

User Image Baruke Posted - 1 week ago

$ESPR $ITRM admittedly was a half cooked idea that can still go terribly wrong, but working out better than expected so far.

User Image vic1torious Posted - 1 week ago

$ITRM I’m a little confused why is the short interest going up when news may drop any minute.

Analyst Ratings
HC Wainwright & Co. Buy Apr 1, 24
HC Wainwright & Co. Buy Mar 6, 24
HC Wainwright & Co. Buy Feb 7, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dunne Michael W. Director Director Dec 22 Buy 1.40 25,000 35,000 113,754 12/27/23
Dunne Michael W. Director Director Nov 22 Buy 2.0345 20,000 40,690 78,754 11/27/23
Fishman Corey N. Chief Executive Offi.. Chief Executive Officer Nov 20 Buy 1.5863 10,000 15,863 54,449 11/20/23
Hecht Beth Director Director Jun 15 Option 0.00 15,853 18,839 06/15/23
Dunne Michael W. Director Director Jun 15 Option 0.00 15,853 53,488 06/15/23
Chin Mark Director Director Jun 15 Option 0.00 15,853 18,306 06/15/23
Dunne Michael W. Director Director Apr 01 Option 0.00 1,299 37,635 06/05/23
HUNT RONALD Director Director Apr 01 Option 0.00 2,041 6,071 04/03/23
Ahrens Brenton Karl Director Director Sep 08 Sell 2.3 33,298 76,585 82,246 09/12/22
Dunne Michael W. Director Director Sep 07 Buy 2.22 10,000 22,200 35,576 09/09/22
Hecht Beth Director Director Jun 23 Option 0.00 36,798 44,805 06/24/22
Dunne Michael W. Director Director Mar 25 Option 0.00 10,494 346,849 03/29/22
Hecht Beth Director Director Mar 18 Option 0.00 7,642 8,007 03/22/22
Matthews Judith M. Chief Financial Offi.. Chief Financial Officer Mar 11 Sell 0.31 63,340 19,635 65,292 03/15/22